|
 |
|
|
Video Endoscopic Sequence 1 of 12.
This is the case of a 44 year-old male who previously had two endoscopies practiced with another collegue, the first one due to epigastric pain, that endoscopy showed two ulcerated nodules at the antrum, biopsies displayed helicobacter pylori and a gastric lymphoma, after the eradication of H pylori the two nodules have been regressed. 3 months after the patient ask for second opinion, we performed this endoscopy presented in this atlas.
|
|
|
 |
|
|
Video Endoscopic Sequence 2 of 12.
This image shows multiple irregular and large ulcers.
|
|
|
 |
|
|
Video Endoscopic Sequence 3 of 12.
The gastrointestinal (GI) tract, particularly the stomach, is the most common primary site of extranodal lymphoma. However, primary gastric lymphoma is uncommon and constitutes only 2%–5% of malignant gastric lesions. Most gastric lymphomas are of B-cell lineage. Among them, most primary low-grade B-cell lymphomas of the stomach have long been known as "pseudolymphomas" or "lymphoreticular hyperplasia" because of the presence of reactive follicles and mixed inflammatory cell infiltration at histopathologic examination and because of the favorable prognosis. However, recent immunohistochemical studies have shown that most pseudolymphomas are monoclonal B-cell proliferations and that the majority of these B cells are considered to originate from mucosa-associated lymphoid tissue (MALT). These B cells have the same cytologic and immunophenotypic characteristics as the B cells that are normally found around the mantle zones of Peyer patches Therefore, these low-grade B-cell lymphomas, which have the morphologic features of MALT with the high-grade lesions that may evolve from them, are known as MALT lymphoma .
|
|
|
 |
|
|
Video Endoscopic Sequence 4 of 12.
Multiple irregular shallow ulcers.
The paradox of lymphomas arising in the stomach has been explained by the observation of MALT in the stomach in response to infections by H pylori and by the presence of this organism in more than 90% of gastric MALT lymphomas. In some cases, low-grade MALT lymphomas have regressed with eradication of H pylori .
|
|
|
 |
|
|
Video Endoscopic Sequence 5 of 12.
MALT lymphoma is an indolent (commonly called low grade) type of B-cell non-Hodgkin lymphoma, first recognised as a specific type of lymphoma in 1983. It occurs at sites that are outside lymph nodes or the spleen. The organisation of the lymphoma cells, when viewed under the microscope, resembles the lymphoid tissue normally found in the gut, which is called ‘mucosa-associated lymphoid tissue (MALT). MALT lymphoma most frequently arises within this type of lymphoid tissue after it has accumulated as part of a reaction to an infection or inflammation.
|
|
|
 |
|
|
Video Endoscopic Sequence 6 of 12.
Chromoendoscopy with indigo carmine stain.
|
|
|
 |
|
|
Video Endoscopic Sequence 7 of 12.
In the new World Health Organisation classification of lymphoid tumours, MALT lymphoma is more correctly called 'extra-nodal marginal zone B-cell lymphoma'. This is because there is now strong evidence to suggest that the type of cell from which the lymphoma develops is a specific B-cell which is founding a specific compartment of the lymphoid tissue called the marginal zone.
|
|
|
 |
|
|
Video Endoscopic Sequence 8 of 12.
MALT lymphoma is the third most common type of non-Hodgkin lymphoma, although it only accounts for about 7-8% of these tumours. MALT lymphomas have been described at almost all extra-nodal sites (sites other than lymph nodes), but are most commonly found in the gastrointestinal tract - the gut - (50% of all MALT lymphomas) within which the stomach is the most frequently involved area (34% overall; 50-70% of gastrointestinal MALT lymphomas). It appears to be a contradiction that MALT lymphomas are found least frequently in sites in which MALT is normally present, like the terminal part of the small intestine, and seem only to develop when the lymphoid tissue arises in response to infection or other cause of inflammation.
|
|
|
 |
|
|
Video Endoscopic Sequence 9 of 12.
Gastric MALT lymphomas account for up to 4% of all primary gastric tumours and 40-50% of all primary gastric lymphomas (the remaining being mostly the more aggressive (commonly called high grade) diffuse large B-cell lymphomas).
MALT lymphomas are approximately equally distributed between men and women. This lymphoma is most frequent in late middle aged/elderly people although it may be found in any age-group.
|
|
|
 |
|
|
Video Endoscopic Sequence 10 of 12.
MALT lymphomas arise at sites that have acquired some MALT-type lymphoid tissue due to some other disease/disorder or infection. For some MALT lymphomas this underlying condition remains a mystery, while for others more is known about predisposing factors. For example, in the thyroid and salivary glands, MALT lymphomas can develop due to autoimmune inflammatory conditions known respectively as Hashimoto’s thyroiditis and Sjogren’s syndrome.
However, most is known about gastric MALT lymphoma, as this is the commonest site at which these lymphomas develop. In the stomach, the majority of these lymphomas are associated with infection by a bacterium called Helicobacter pylori This causes inflammation of the lining of the stomach which includes the development of MALT-type lymphoid tissue. Once the MALT-type tissue is acquired, there is continuous stimulation of the lymphocytes to replicate and increase in number as a result of the constant presence of bacteria (a normal immune reaction). However, in a small minority of people, this results in a mistake within the genetic material of a lymphoid cell and continuation of this faulty cell line leads to the development of a lymphoma.
|
|
|
 |
|
|
Video Endoscopic Sequence 11 of 12.
Until the early 1990's surgery was probably the most commonly used treatment for gastric MALT lymphoma. However, with the recognition of the common association between gastric MALT lymphoma and Helicobacter infection and following some laboratory-based studies on cells derived from lymphomas, it was suggested that eradication of Helicobacter alone might have a therapeutic effect. Further studies some of which now have follow-up extending to over ten years, have shown that eradication of Helicobacter alone can induce tumour regression in 50-70% of cases. The cases that respond the best are those that have not extended very far through the gastric wall and have not spread to lymph nodes. An initial antibiotic-based regime for eradication is usually prescribed, followed by endoscopies to confirm eradication of the organism and to assess tumour response.
The interval between Helicobacter eradication and regression of the tumour is highly variable between patients. A proportion of patients will not respond to eradication therapy alone and will go on to more conventional anti-lymphoma therapies such as chemotherapy or radiotherapy. There is, at present, no clear agreement between doctors as to when eradication therapy can be assessed as having failed in an individual, but while there are sequential improvements in biopsies taken during endoscopies, it may be worth delaying the use of other therapies. Some cases have been reported where there has been regression of the lymphoma many years after eradication and in the absence of other therapies.
|
|
|
 |
|
|
Video Endoscopic Sequence 12 of 12.
When Helicobacter eradication has been deemed to have failed, more conventional therapies can be used. While surgery has, in the past, been the mainstay of treatment for gastric lymphoma, this is no longer the case. Several studies have shown that, although the lymphoma is usually concentrated in one part of the stomach, there are small deposits all over the stomach lining.
Both radiotherapy and chemotherapy have been shown to be highly effective in the treatment of gastric MALT lymphoma. Single-agent chemotherapy with alkylating agents (substances which are used to treat some cancers by interfering with cell metabolism and growth) such as cyclophosphamide or chlorambucil or nucleoside analogues (other drugs used to check the growth of lymphoma cells) such as cladribine appear to have equal activity.
|
|
|
 |
|
|
Endoscopic Sequence 1 of 15.
Gastric lymphoma with metastases to the duodenum.
This 74 year-old male with weigh loss of 20 pounds and vomiting.
The image and the video clip shows a large mass in the duodenal bulb.
|
|
 |
|
|
Endoscopic Sequence 2 of 15.
Post bulbar metastases.
|
|
|
 |
|
|
Endoscopic Sequence 3 of 15.
Another view of the mass in the duodenal bulb.
|
|
|
 |
|
|
Endoscopic Sequence 4 of 15.
Retroflexed view in the duodenum showing the large mass in the bulb in the limit of the second part of the duodenum.
|
|
|
 |
|
|
Endoscopic Sequence 5 of 15.
Retroflexed view from a little more far.
|
|
|
 |
|
|
Endoscopic Sequence 6 of 15.
The Pre-pyloric antrum is showed with infiltration with the neoplasia.
|
|
|
 |
|
|
Endoscopic Sequence 7 of 15.
The antrum with extensive malign infiltration.
|
|
|
 |
|
|
Endoscopic Sequence 8 of 15.
The gastric angle is infiltrated.
|
|
|
 |
|
|
Endoscopic Sequence 9 of 15.
Some rest of food is observed.
|
|
|
 |
|
|
Endoscopic Sequence 10 of 15.
In this image shows the freshness of the banana in the middle of neoplasia is evident.
|
|
|
 |
|
|
Endoscopic Sequence 11 of 15.
Again, post bulbar metastases.
|
|
|
 |
|
|
Endoscopic Sequence 12 of 15.
|
|
|
 |
|
|
Endoscopic Sequence 13 of 15.
|
|
|
 |
|
|
Endoscopic Sequence 14 of 15.
|
|
|
 |
|
|
Endoscopic Sequence 15 of 15.
|
|
|
 |
|
|
Gastric Lymphoma.
B-Cell Lymphoma.
Non-Hodgkin's Lymphomas caused by malignant (cancerous) B-Cell lymphocytes represent a largesubset (about 85% in the US) of the known types of lymphoma (the other 2 subsets being T-Cell lymphomas and lymphomas where the cell type is unknown). B-Cells undergo many changes in their life cycle dependent on complex signaling processes between cells and interaction with foreign substances in the body. Apparently various types of lymphoma or leukemia can occur in the B-Cell life cycle.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
|
|
Malt Lymphoma.
Small cell lymphomas may resemble reactive lymphoid hyperplasia. Lymphomatous involvement of the stomach may have a variety of manifestations, including large infiltrated rouge, eroded nodules and exophytic and ulcerated masses, erosions and ulcers.
|
|
|
 |
|
|
Video Endoscopic Sequence 1 of 7.
Non-Hodking Lymphoma B Cells.
|
|
|
 |
|
|
Video Endoscopic Sequence 2 of 7.
Non-Hodking Lymphoma
|
|
|
 |
|
|
Video Endoscopic Sequence 3 of 7.
Lymphoid Neoplasia that substitutes the gastric mucosa.
|
|
|
 |
|
|
Video Endoscopic Sequence 4 of 7.
Cytokeratine negative by Inmunohistochemistry.
|
|
|
 |
|
|
Video Endoscopic Sequence 5 of 7.
LCA positive
|
|
|
 |
|
|
Video Endoscopic Sequence 6 of 7.
CD20: Positive in cells tumor.
|
|
|
 |
|
|
Video Endoscopic Sequence 7 of 7.
CD3: Negative.
Non-Hodking Lymphoma B Cells.
|
|
|
 |
|
|
Systemic Lymphoma.
There are several lesions in the stomach that histologically and proved to be systemic lymphoma.
|
|
|
 |
|
|
Video Endoscopic Sequence 1 of 3.
Non-Hodking Lymphoma
|
|
|
 |
|
|
Video Endoscopic Sequence 2 of 3.
Non-Hodking Lymphoma
|
|
|
 |
|
|
Video Endoscopic Sequence 3 of 3.
Non-Hodking Lymphoma
|
|
|
|
 |
|